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Abstract
Background: Young children bear the world’s highest prevalence of anaemia, the majority of which is of multifactorial
aetiology, which in turn hampers its successful prevention. Even moderate degrees of anaemia are associated
with increased mortality and morbidity. Despite this evidence, there is a lack of effective preventive programs
and absence of consensus in the safety of iron supplementation in malaria areas, which reflects the poor understanding
of the contribution of different aetiologies to anaemia. In order to reduce the anaemia burden in the most
vulnerable population, a study to determine the aetiology of anaemia among pre-school Mozambican children was
performed.
Methods: We undertook a case–control study of 443 preschool hospitalized children with anaemia (haemoglobin
concentration <11 g/dl) and 289 community controls without anaemia. Inclusion criteria were: age 1–59 months,
no blood transfusion in the previous month, residence in the study area and signed informed consent. Both univariable
and multivariable logistic regression analyses were performed to identify factors associated with anaemia and adjusted
attributable fractions (AAF) were estimated when appropriate.
Results: Malaria (adjusted odds ratio (AOR) = 8.39, p < 0.0001; AAF = 37%), underweight (AOR = 8.10, p < 0.0001;
AAF = 43%), prealbumin deficiency (AOR = 7.11, p < 0.0001; AAF = 77%), albumin deficiency (AOR = 4.29, p = 0.0012;
AAF = 30%), HIV (AOR = 5.73, p = 0.0060; AAF = 18%), and iron deficiency (AOR = 4.05, p < 0.0001; AAF = 53%)
were associated with anaemia. Vitamin A deficiency and α-thalassaemia were frequent (69% and 64%, respectively in
cases) but not independently related to anaemia. Bacteraemia (odds ratio (OR) = 8.49, p = 0.004), Parvovirus-B19
(OR = 6.05, p = 0.017) and Epstein-Barr virus (OR = 2.10, p = 0.0015) infections were related to anaemia only in
the unadjusted analysis. Neither vitamin B12 deficiency nor intestinal parasites were associated with anaemia.
Folate deficiency was not observed.
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Conclusions: Undernutrition, iron deficiency, malaria, and HIV are main factors related to anaemia in hospitalised
Mozambican preschool children. Effective programs and strategies for the prevention and management of
these conditions need to be reinforced. Specifically, prevention of iron deficiency that accounted in this study
for more than half of anaemia cases would have a high impact in reducing the burden of anaemia in children living
under similar conditions. However this deficiency, a common preventable and treatable condition, remains neglected
by the international public health community.
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Background
Despite significant improvements over the last two decades,
global anaemia prevalence in 2010 was 33%, causing 68
million years lived with disability, more than other major
causes such as chronic respiratory diseases, with Sub-
Saharan Africa being the most affected region [1, 2].
Anaemia increases the risk of child mortality while iron de-
ficiency (ID) has consequences on cognitive and physical
development of children [3, 4]. Young children had the
highest prevalence in all areas, being this age group the only
in which anaemia prevalence increased from 1990 to 2010
[2]. Previous information from Mozambique showed that
74.7% of children between 6 months and 5 years were
anemic, having haemoglobin (Hb) ≤5 gr/dl 11.5% of them
[5]. Mean Hb concentration showed insignificant differ-
ences between regions [5]. In Mozambique anaemia has
been reported by the Ministry of Health to be the main
nutritional disease since 1996, but no information about
the aetiology is available [6, 7].
Despite causing such high levels of disability, the
public health community does not pay anaemia the
attention it deserves. This lack of prioritisation may be
partly due to the habit of treating anaemia as a by-
product of other disease processes [3, 8]. Therefore,
the World Health Organization (WHO) has empha-
sised the need of addressing the aetiology of anaemia
in different populations [8]. In addition, the WHO
guidelines for prevention of ID [3], are rarely imple-
mented due to the commonly held view that iron
supplementation increases the susceptibility to some
infectious diseases mainly in non-iron deficient children,
and the lack of iron status markers in low income settings
[9]. With the aim of providing evidence to guide control
policies, a study to determine the anaemia risk factors was
undertaken in hospitalised pre-school children in rural
Mozambique, where the causes of anaemia are poorly
understood [6, 7].
Methods
Study design
The study was conducted at the Centro de Investigação
em Saúde de Manhiça (CISM) and the Manhiça District
Hospital (MDH), Southern Mozambique. The CISM
runs a continuous Demographic Surveillance System
(DSS) and round-the-clock morbidity surveillance at the
MDH. The area has been described in detail elsewhere
[10]. Briefly, malaria was main cause of death in the area
(21.8% of cases) followed by pneumonia (9.8%), HIV/
AIDS (8.3%) and diarrhoea (8%) [11]. Malaria transmis-
sion is perennial with marked seasonality and mainly due
to Plasmodium falciparum [12]. The HIV prevalence in
adults (18–47 years of age) was 37.5% [13] and 1.4% in
children ≤11 years old [14]. The HIV-mother-to-child-
transmission rates in the first month and at 12 months of
age were 9% and 27%, respectively [15]. Almost half (47%)
of children visited in the out-patient clinic presented
some degree of undernutrition being 6% of them se-
verely malnourished [16].
A case–control study was designed to recruit 450
hospital anaemia cases and 450 community controls.
All children with clinical criteria for hospital admission
with ages of 1–59 months, no history of blood transfu-
sion in the previous month and residence in the CISM
DSS area were offered participation in the study. Hb
levels were determined with the Hemocue HB 201+ sys-
tem (Änghelom, Sweden) in children whose guardians
signed the informed consent and those with Hb <11 g/
dl were recruited as cases. Recruitment was consecu-
tive, from October 2008 to August 2010, running con-
tinuously during working hours (8:00–16:00). In order
to avoid the confounding effect of malaria seasonality, a
maximum of ten cases per week were recruited until
reaching 450 cases.
Community controls were randomly selected from
the DSS among children between 1 and 59 months of
age, and visited at home by project personnel. Hb
levels were determined by Hemocue in children with
no history of blood transfusion in the previous month
whose guardians had signed the informed consent.
Those with Hb ≥11 g/dl were invited to a study visit
at the MDH. Due to the high prevalence of anaemic
children in the community (91%) (unpublished data),
only 289 community controls were recruited. Enrol-
ment of cases and controls occurred concurrently.
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The recruitment of hospital controls, which would have
allowed ruling out possible confounding factors associated
with being severely sick, was not possible due to the
extremely high prevalence of anaemia among admitted
children in this setting. Similarly, due to the high preva-
lence of anaemia in the community, it was not possible to
enrol the planned sample size of controls. The implica-
tions of this limitation on the results would depend on the
assumptions made as to the proportion of controls ex-
posed to the factor.
The results of the clinical examination and socio-
demographic information were entered into standardised
questionnaires. Four mL of venous blood was drawn,
blood smears and filter paper blood smears were made. A
maximum of 1 ml/kg was drawn from children. A stool
and a urine sample were collected whenever possible.
Laboratory methods
Haematological studies
Blood counts, different from haemoglobin, were per-
formed using a Sysmex analyser KX21N or XT-2000i
(Sysmex Long Grove, IL, USA). Reticulocyte counts
were estimated by microscopy on cresil blue-stained
blood smears.
Biochemical studies
Albumin, prealbumin, and C-reactive protein (CRP) levels
were measured with an ADVIA 2400 analyser (Siemens
Healthcare, Spain). Folic acid, vitamin B12 and ferritin
levels were measured with an ADVIA Centaur (Siemens
Healthcare, Spain). sTfR levels were measured in a BN-II
nephelometer (Dade-Siemens Healthcare, Spain) and vita-
min A levels by reversed phase high-performance liquid
chromatography [17]. Erythropoietin quantification was
performed using the Quantikine human erythropoietin
immunoassay kit (R&D Systems, USA).
Bacteriological, virological and parasitological studies
Bacteria were detected in blood cultures in the BAC
TEC® 9050 (Becton-Dickinson, USA). In children
≤18 months of age HIV infection was defined as a
HIV-1 DNA-positive result, detected using the Ampli-
cor HIV-1 DNA-PCR kit (Roche Diagnostics, USA)
and in older children it was defined as two positive
rapid tests, using the Determine HIV-1/2 Rapid Test
(Abbott Laboratories, USA) and confirming by the
Uni-Gold Rapid Test (Trinity Biotech Co., Ireland), or
as discordant rapid test results resolved by an add-
itional HIV DNA-positive result. Epstein-Barr virus
(EBV) and Parvovirus B19 (PV-B19) were identified by
real time quantitative PCR (qPCR) using the Artus
PCR kits (QIAGEN, Spain). Plasmodium falciparum (Pf)
parasites were identified by microscopy on Giemsa-stained
blood films. Pf qPCR was performed for microscopically
negative samples. Schistosoma haematobium was deter-
mined by direct microscopic examination of urine sediment
[18]. Intestinal parasites in stool (see Table 3 for details)
were detected by microscopic examination using the
merthiolate-iodine-formalin concentrations method [19].
Genetic studies
Haemoglobinopathies and β-thalassaemia were assessed
using the β-thalassaemia Short Program from the Vari-
ant Haemoglobin Testing System® (Bio-Rad, Hercules,
USA). Detection of α-thalassaemia (3.7 kb deletion)
was performed by the GAP-PCR method [20]. Glucose 6-
phosphate dehydrogenase (G6PD) deficiency was deter-
mined using the Beutler fluorescent spot test [21].
Definitions
Anaemia was categorised as severe (Hb <5 g/dl) or
moderate (Hb ≥5 g/dl to <11 g/dl). Fever was defined
as axillary temperature ≥37.5 °C. Bacteraemia was
defined as at least one bacterium isolated in blood
(excluding common contaminants listed in Table 3).
Pf infection was defined as the presence of asexual
parasites in blood by microscopy or qPCR. Clinical
malaria was defined as Pf infection plus fever or a
history of fever in the preceding 24 h. Detection of
parasites by qPCR and a negative blood smear defined
submicroscopic Pf infections. Hyperparasitaemic Pf in-
fection was defined as >100,000 parasites/μl of blood.
EBV and PV-B19 infections were defined as detection
of the virus in blood by qPCR.
Wasting was defined as a weight-for-height/length Z-
score (WHZ) of < −2 standard deviations (SD), stunting
as height-for-age Z-score (HAZ) < −2 SD and under-
weight as weight-for-age Z score (WAZ) < −2 SD [22].
Albumin deficiency was defined as <34 g/l (laboratory
reference value), and prealbumin deficiency as <0.142 g/l
in children <6 months of age, <0.120 g/l in children 6–
12 months of age and <0.108 g/l in children 13–59
months of age [23]. Folate deficiency was defined as
<3 ng/ml (laboratory reference value), vitamin A defi-
ciency as <20 μg/dl [24], and vitamin B12 deficiency as
<200 pg/ml [25]. ID was defined as the ratio of soluble
transferrin receptor to log ferritin (TfR-F index) >1.5 if
CRP <1 mg/dl, and >0.8 if CRP ≥1 mg/dl. This bio-
marker was identified as the best predictor of ID with an
accuracy of 71%, using the bone marrow iron content as
the gold standard [9]. In order to compare ID prevalence
between cases and controls, this ID definition was used
instead of bone marrow iron content, as bone marrow
examination was undertaken in anaemic children only
[9]. Inflammation was defined as a CRP level ≥1 mg/dl.
Ineffective erythropoiesis was a Reticulocyte Production
Index <2 [26].
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Statistical analysis
Data were double entered using Microsoft Visual FoxPro
5.0 (Microsoft Corp., USA) and analysed using STATA
12 (STATA Corporation, College Station, USA). Crude
comparisons were performed by Chi-square or Fisher’s
exact tests for proportions, and the Student’s t test or
Wilcoxon rank sum test for means or medians, respectively.
Multivariable logistic regression analysis was performed by
stepwise selection including all variables with p-value <0.05
in the crude models, using significance levels of 0.05 and
0.10 for addition to and for removal from the model,
respectively. Among the variables with no significant
association with anaemia in the univariable model
only vitamin B12 and G6PD deficiencies were in-
cluded in the multivariable model based on biologic
plausibility. Intestinal parasitic infections, schistosoma in-
fection, haemoglobinopathy type E, sickle cell trait and
β-thalassaemia trait were not included because of their
low prevalence. No children in the control group had
clinical malaria or hyperparasitemia, so these variables
were not included in the regression models. Due to the
difficulty in obtaining sufficient volume of blood sam-
ples in some children, α-thalassaemia was analysed in
only 258 subjects and it was also excluded from the
regression analysis. Missing observations were ex-
cluded from the multivariate model. Attributable frac-
tion (AF) were estimated using Bruzzi’s approach [27].
The variance of adjusted AF (AAF) was approxi-
mated by Taylor series to first derivative terms (delta
method) [28].
Results
Characteristics of the participants
During the study period 736 children were enrolled. Six
children were recruited twice and were included in the
first group in which they participated; one case older
than 5 years of age was excluded. The analysis was
restricted to 443 cases and 289 community controls
(Fig. 1). Demographic, clinical and socioeconomic char-
acteristics of participants are shown in Tables 1 and 2.
Risk factors associated with anaemia
The distribution of risk factors associated with anaemia
is summarised in Table 3. Adjusted (for age and sex)
Odds Ratios (AOR) from the univariable analysis are
shown in Fig. 2.
Undernutrition
Cases were more wasted, stunted and underweight than
controls (p < 0.0001 for all three parameters, Table 3).
Deficiencies in albumin and prealbumin were more
prevalent in cases than in controls. ID was found in 69%
(263/381) of cases and 43% (111/260) of controls (p <
0.0001). ID was more frequent among children with
moderate anaemia [70%(241/346)] than those with se-
vere anaemia [63%(22/35)] or in controls [43%(111/260);
p < 0.0001]. The crude AF of ID was 47%, 95%CI [39,
55] for moderate anaemia and 35%, 95%CI [15, 55] for
severe anaemia. Vitamin A deficiency was more frequent
in cases, while vitamin B12 deficiency was similar in
both groups (p = 0.28). Folate deficiency was not found.
Bacteraemia
Cases had a higher prevalence of bacteraemia than con-
trols [8%(34/433) vs. 1%(3/286); p = 0.0001]. The most
commonly isolated bacteria was Streptococcus pneumo-
niae (32%). Among the cases, bacteraemia was similar
between children with and without ID [7%(17/258) vs.
8%(9/115); p = 0.6649].
Viral infections
Cases had a higher prevalence than controls of infec-
tions with HIV [21%(93/443) vs. 2%(6/289); p < 0.0001],
PV-B19 [6%(26/443) vs. 2%(6/287); p = 0.0149] and EBV
[27%(117/441) vs. 14%(39/286); p < 0.0001].
Parasitic infections
Pf infection was present in 42%(179/428) of cases and
7%(21/287) of controls (p < 0.0001). Among the cases,
the prevalence of clinical malaria was similar between
those with ID [44%(114/258)] and those without it
Fig. 1 Recruitment flow chart
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[40%(45/111)] (p = 0.5166). Among children with severe
anaemia, 71% (25/35) had Pf parasitemia compared to
39% (154/393) of those with moderate anaemia (p <
0.0001). The prevalence of intestinal parasitic infections
was low in both groups [controls 6% (10/154) vs. cases
3%(6/205); p = 0.1051)].
Erythrocyte genetic disorders
α-thalassaemia was found in 53% of tested children,
being more prevalent in cases [64%(77/121) with 16%
homozygous (a-/a-) and 48% heterozygous (aa/a-)] than
in controls [43%(59/137) with 15% homozygous and 28%
heterozygous); p = 0.0010]. The frequency of G6PD
Table 1 Demographic and clinical characteristics of cases and community controls
Characteristic Study groups p-value
Cases Controls
Gender1 (male) 261/443 (59%) 132/289 (46%) 0.00042
Age (months)3 19.40 (14.08) [443] 26.61 (18.51) [289] <0.00014
Jaundice1 5/443 (1%) 0/288 (0%) 0.16285
Palpable spleen1 96/443 (22%) 1/288 (0%) <0.00012
Fever1 389/443 (88%) 1/289 (0%) <0.00012
Haemoglobin g/dl3 7.88 (1.98) [443] 11.66 (0.75) [289] <0.00014
Haemoglobin < 5 g/dl1 40/443 (9%) 0/289 (0%) <0.00012
MCV (fl)3 71.53 (9.64) [427] 75.63 (7.02) [270] <0.00014
MCHC (g/dl)6 32.60 (4.20) [425] 34.00 (3.30) [270] <0.00017
RBC distribution width-sd (fl)6 45.40 (9.60) [420] 41.75 (6.10) [270] <0.00017
White Blood Cells (x103/μl)8 10.54 (7.54) [426] 8.75 (3.44) [272] <0.00014
CRP (mg/dl)6 5.99 (10.77) [432] 0.05 (0.25) [282] <0.00017
EPO (U/l)6 53.45 (176.10) [434] 10.50 (7.00) [283] <0.00017
Inflammation1 356/432 (82%) 27/282 (10%) <0.00012
Insufficient erythropoiesis1 311/326 (95%) 172/195 (88%) 0.00222
Duration of infant admission (days)3 4.93 (4.94) [426] -
Outcome of admission1 Alive 386/425 (91%) -
Died 13/425 (3%) -
Left 13/425 (3%) -
Transferred 13/425 (3%) -
1n/N (percentage); 2Chi-squared test; 3Arithmetic mean (SD) [n]; 4t-test; 5Fisher’s exact test; 6Median (IQR) [n]; 7Wilcoxon Rank Sum test; 8Geometric mean (SD) [n]
Abbreviations: CRP C-reactive protein, EPO Erythropoietin, MCHC Mean cell haemoglobin concentration, MCV Mean cell volume, RBC Red blood cells
Table 2 Socioeconomic characteristics of cases and community controls
Characteristic Study groups p-value
Cases Controls
Mother’s age (years)1 25.59 (6.31) [376] 26.50 (7.03) [281] 0.08262
Number of children1 1.73 (1.61) [354] 1.99 (1.85) [270] 0.05492
Marital status3 Married 17/432 (4%) 7/279 (3%) 0.40064
Union 295/432 (68%) 207/279 (74%)
Maiden 89/432 (21%) 44/279 (16%)
Separate 20/432 (5%) 13/279 (5%)
Widow 11/432 (3%) 8/279 (3%)
Mother was educated3 255/440 (58%) 199/287 (69%) 0.00194
Mother works outside home3 111/443 (25%) 190/289 (66%) <0.00014
House of cement3 149/443 (34%) 126/289 (44%) 0.00654
Number of rooms5 1 (1) [443] 2 (2) [289] <0.00016
1Arithmetic mean (SD) [n]; 2t-test; 3n/N (percentage); 4Chi-squared test; 5Median (IQR) [n]; 6Wilcoxon Rank Sum test
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deficiency was similar in the two groups [cases 10%(44/
236) vs. controls 8%(22/271); p = 0.3805]. Four children
with sickle cell trait but no cases of sickle cell disease
were identified. The β-thalassaemia trait was observed in
one case and four controls.
Multivariable analysis
Age, underweight, deficiencies of prealbumin, albumin
and iron, and Pf and HIV infections were factors inde-
pendently associated with anaemia (Table 4). The two
main AAF of anaemia were prealbumin deficiency and
ID, (77%, 95% CI [69, 86], and 53%, 95% CI, [42, 64],
respectively), followed by underweight (43%, 95% CI
[39; 48]), and Pf infection (37%, 95% CI [33, 41]). The
AAF of anaemia associated with HIV infection was 18%
(95% CI [13, 22]) (Table 4).
Discussion
This paper describes a novel study on the aetiology of
anaemia in hospitalised children with varying degrees of
anaemia. The findings confirm the multifactorial and
overlapping aetiology of anaemia and indicate that
Table 3 Distribution of possible aetiological and confounding factors of anaemia among cases and community controls
Variable Study groups Total p-value
Cases Controls
Undernutrition
Underweight (WAZ < −2)1 197/443 (44%) 32/284 (11%) 229/727 (31%) <0.00012
Wasted (WHZ < −2)1 134/446 (31%) 18/280 (6%) 152/716 (21%) <0.00012
Stunted (HAZ < −2)1 141/436 (32%) 35/284 (12%) 176/720 (24%) <0.00012
Albumin deficiency1 175/432 (41%) 11/282 (4%) 186/714 (26%) <0.00012
Prealbumin deficiency1 389/430 (90%) 97/280 (35%) 486/710 (68%) <0.00012
Iron deficiency1 263/381 (69%) 111/260 (43%) 374/715 (58%) <0.00012
Folate deficiency1 0/381 (0%) 0/255 (0%) 0/636 (0%)
Vitamin A deficiency1 301/434 (69%) 79/283 (28%) 380/717 (53%) <0.00012
Vitamin B12 deficiency1 68/413 (16%) 53/269 (20%) 121 (18%) 0.27942
Viral infections
HIV1 Negative 297/443 (67%) 266/289 (92%) 563 (77%) <0.00012
Positive 93/443 (21%) 6/443 (2%) 99 (14%)
Indeterminate 4/443 (1%) 0/443 (0%) 4 (1%)
Not done 49/443 (11%) 17/443 (6%) 66 (9%)
Parvovirus B19 infection1 26/436 (6%) 6/287 (2%) 32/730 (4%) 0.01492
EBV infection1 117/441 (27%) 39/286 (14%) 156/727 (21%) <0.00012
Bacteraemia1 34/433 (8%)4 3/286 (1%)5 37/719 (5%) 0.00012
Parasitic infections
Plasmodium falciparum1 179/428 (42%) 21/287 (7%) 200/715 (28%) <0.00012
Hyperparasitemic Pf.1 34/428 (8%) 0/287 (0%) 34/715 (5%) <0.00012
Submicroscopic Pf.1 37/322 (11%) 12/284 (4%) 49/666 (8%) 0.00112
Clinical malaria1 172/428 (40%) 0/287 (0%) 172/715 (24%) <0.00012
Intestinal parasites1 6/205 (3%)6 10/154 (6%)7 16/359 (4%) 0.10512
Schistosoma haematobium1 0/172 (0%) 0/175 (0%) 0/347 (0%) -
Genetic disorders
G6PD deficiency1 44/436 (10%) 22/271 (8%) 66/707 (9%) 0.38052
Haemoglobinopathy1,8 4/431 (1%) 2/263 (1%) 6/694 (1%) 1.00003
β-Thalassaemia1 1/431 (0%) 4/263 (2%) 5/694 (1%) 0.07113
α-Thalassaemia1 77/121 (64%) 59/137 (43%) 136/258 (53%) 0.00102
1n/N (column percentage); 2Chi-squared test; 3Fisher’s exact test; 411 Streptococcus pneumoniae, 5 Staphylococcus aureus, 5 Escherichia coli, 3 Salmonella typhimurium, 10
others. 51 E. coli, 1 Klebsiella spp and 1 g negative bacilli, lactose fermenting oxidase negative (these findings were considered contaminations or transient bacteraemia);
6the intestinal parasites are 3 Ascaris lumbricoides, 2 Giardia lamblia, 1 Strongyloides stercoralis, 7the intestinal parasites are 6 Ascaris lumbricoides, 2 Giardia lamblia,
1 Entamoeba hystolitica, 1 Strongyloides stercoralis, 8Haemoglobinopathy includes S and E
Abbreviations: EBV Epstein-Barr virus, G6PD Glucose 6 phosphate dehydrogenase, Pf Plasmodium falciparum, WAZ Weight for age Z score
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undernutrition, ID and malaria and HIV infections are
the main factors associated with anaemia. These factors
should be prioritised in public health interventions in
order to decrease the prevalence of a disease which
affects to a 33% of the world population, mainly children
in low resource settings [2].
The extremely high prevalence of overall anaemia in
children admitted to the MDH (Moraleda et al., unpub-
lished data) highlights the impact of anaemia among
children in this area, which prevented the inclusion of a
hospitalised control group. The resulting absence of
hospital controls and the absence of a case group from the
community could result in an overestimation of the effect
of diagnoses associated with hospital admission (including
HIV, malaria and other infections), which should be taken
into account before extrapolate these results to the non-
hospitalised population. On the other hand, as it has been
reported, hospital controls may provide weaker or null
estimates of the associations compared with community
controls because of the high frequency of co-morbidities
in this group [29]; for example, it is quite likely that
hospital controls may not reveal the association of malaria
or HIV with anaemia since these are quite frequent condi-
tions among hospitalised children in this setting.
Fig. 2 Odds Ratios adjusted for age and gender for factors associated with anaemia, according groups. Abbreviations: CRP C-reactive protein,
G6PD Glucose 6 phosphate dehydrogenase, TfR-F index ratio of soluble transferrin receptor to log ferritin, WAZ Weight for age Z score
Table 4 Adjusted odds ratios from logistic regression model and adjusted attributable fractions for anaemia
Risk factor Proportion of
cases with
factor (%)
Adjusted association AAF AC
OR (95% CI) p-value Estimate (%) (95% CI)
Prealb def. 90.1 7.11 (3.55; 14.24) <0.0001 77.42 (68.62; 86.23) 235
Underweight 49.2 8.10 (3.82; 17.18) <0.0001 43.10 (38.54; 47.67) 131
Pf infection 42.2 8.39 (3.82; 18.40) <0.0001 37.21 (33.25; 41.16) 113
Iron def. 70.0 4.05 (2.16; 7.61) <0.0001 52.71 (41.85; 63.57) 160
Albumin def. 39.6 4.29 (1.78; 10.35) 0.0012 30.37 (22.24; 38.51) 92
HIV 21.5 5.73 (1.65; 19.92) 0.0060 17.71 (13.05; 22.37) 54
All risk factors in model 97.51 (96.16; 98.87) 295
Abbreviations: AAF Adjusted attributable fractions, AC Attributable cases, CI Confidence interval, def: deficiency, Pf Plasmodium falciparum, Prealb Prealbumin, OR
Odds Ratio
The odds ratios presented in this table were adjusted for all the variables included in it. In addition, they were also adjusted for the socio-demographic characteristics
that were significant in that multivariable model (age and “mother works outside home”). As these variables were protective, their AAF were not calculated
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Albumin and prealbumin deficiencies were very preva-
lent among cases and nearly 50% exhibited underweight.
Both proteins are markers of malnutrition, but they are
also affected by inflammation [30], explaining why these
factors were independently associated with anaemia. In
contrast, vitamin A deficiency was not independently
related to anaemia. This might be attributable to the
association of reduced albumin and prealbumin with
vitamin A deficiency [31]. On the other hand, vitamin A
deficiency might have been overestimated as vitamin A
decreases with inflammation [32]. Alternatively, it may
also reflect a poor uptake of vitamin A supplementation
programs, suggesting that monitoring of the effective-
ness of these programs should be considered a critical
addition to public health policies.
While CRP test does serve as a general marker for in-
fection and inflammation, it is not specific enough to
diagnose a particular disease. Inflammation, defined by
an elevated CRP level, was very common among cases
(82%), and thus it was identified as a major risk factor
for anaemia. However, this association is difficult to in-
terpret because it actually hides the associations with
other underlying factors; for this reason CRP was not in-
cluded in the multivariable analysis.
In contrast with previous observations in Malawi [33],
and similarly to other reports [34], vitamin B12 defi-
ciency was not associated with a risk of anaemia in this
study. The general evidence suggests that vitamin B12
deficiency is not a major contributor to anaemia in all
settings in Africa.
In this study, folate deficiency was not detected. This
may have been underestimated because of difficulties in
measuring folate plasma levels [35], or to an increase of
folate levels caused by haemolysis during malaria [36];
however, folate levels were also high in children without
malaria. Tests with increased sensitivity to measure folate
are needed in malaria-exposed populations [35].
The proportion of children with Pf parasitemia was in-
creased in those with severe anaemia, suggesting that
malaria may contribute more to severe than to moderate
anaemia.
Anaemia is one the most frequent signs among HIV-
infected children, so the observed association between
both conditions was expected [37]. HIV-related anaemia
has been mainly associated with uncontrolled HIV-
disease, opportunistic infections and nutritional deficien-
cies, but also to the use of drugs such as zidovudine and
cotrimoxazole [38]. At recruitment, the HIV status was
known by the relatives in only 44% of the HIV-infected
children of the study and from those less than a quarter
were on antiretroviral treatment (most of them including
zidovudine) and 11% referred to be on cotrimoxazole
prophylaxis, both with unknown levels of adherence
(data not shown). A direct effect of the HIV as one
of the main causes of anaemia was expected, but the
lack of the RNA-HIV viral loads results limits this
conclusion. Other studied aetiologies, such as under-
nutrition and bacteriemia, seem to have a role in the
anaemia of the HIV-infected children in this study
(data not shown).
Prevalences of bacteraemia, PV-B19 and EBV infections
were higher in cases than in controls, but no independently
related to anaemia. This may be due to the association of
these infections with other factors included in the model,
such as HIV and malaria [33, 39, 40].
Helminthic infections were rare and not associated
with anaemia. These findings, consistent with pub-
lished data among pre-school children [41, 42] and
with studies in this same setting where molecular
techniques were used (Mandomando et al. unpub-
lished data), are relevant when considering the target
age groups of deworming programs.
In agreement with previous observations in Mozambique,
the prevalence of sickle cell trait was very low [43]. On the
other hand, more than 50% of those in whom it was
tested presented with heterozygous or homozygous
α-thalassaemia, indicating that mean cell haemoglo-
bin concentration is not a suitable marker of iron
status in populations with a high prevalence of the
α-thalassaemia trait [9]. G6PD deficiency was not
associated with an increased risk of anaemia despite
most cases harbouring infections, the main risk fac-
tor to develop anaemia in children with G6PD defi-
ciency [44].
An important fraction of anaemia was due to ID (AAF
53%), indicating that its prevention might have a consider-
able impact in reducing anaemia prevalence. The asso-
ciation of ID with anaemia was in contrast with data
from Malawi where ID was related to a reduced risk of
severe anaemia [33]. The authors explain their finding
by the observed inverse association between ID and
bacteraemia, and the contribution of bacteraemia to
anaemia [33]. In the current study, ID was not associ-
ated with a reduced prevalence of bacteraemia among
cases. The dissimilar observations could be explained
by different definitions of study groups, and distinct
contributions of ID to anaemia depending on its severity.
In the Malawian study, cases were children with severe
anaemia and controls were children with Hb ≥5 g/dL,
whereas all degrees of anaemia were included in the cases
in the study presented here and controls were not an-
aemic. The protective effect of ID against severe anaemia
in the Malawian study was based on a greater prevalence
of ID among controls (most of whom had moderate
anaemia). This actually concords with the findings in the
present study where ID appeared to contribute more to
moderate than to severe anaemia, where other factors
might play a more important role.
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Despite the identification of ID as the 4th greatest risk
factor for burden of disease in sub-Saharan Africa [1], its
prevention in children exposed to malaria remains unre-
solved. Discrepancies between the Cochrane review, which
concludes that iron supplementation does not adversely
affect children living in malaria areas [45], and the WHO
guidelines which recommend iron supplementation in
these areas only if children have proven to be iron defi-
cient [46], leads to the absence of preventive programs for
this significant global health problem.
Conclusions
In hospitalized Mozambican preschool children, un-
dernutrition, and ID were found significantly associ-
ated with anaemia, indicating that their prevention
may have a major impact. Malaria and HIV infections
were also important contributors to anaemia but the
impact of their control would be place specific. These
findings should inform the development of future
interventional studies (such as those focused on iron
supplementation or nutritional improvement), which
would then guide the design of effective programs to
prevent anaemia, a major killer of young children in
developing countries.
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